# Study of Single Doses of IV Aerucin in Healthy Adults

> **NCT02486770** · PHASE1 · COMPLETED · sponsor: **Aridis Pharmaceuticals, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Aerucin 2.0mg/kg
- **BIOLOGICAL:** Aerucin 8.0mg/kg
- **BIOLOGICAL:** Aerucin 20.0 mg/kg

## Key facts

- **NCT ID:** NCT02486770
- **Lead sponsor:** Aridis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02486770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02486770, "Study of Single Doses of IV Aerucin in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02486770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*